首页> 外文期刊>Journal of periodontal research >The effect of liraglutide on the proliferation, migration, and osteogenic differentiation of human periodontal ligament cells
【24h】

The effect of liraglutide on the proliferation, migration, and osteogenic differentiation of human periodontal ligament cells

机译:Liraglutide对人牙周韧带细胞增殖,迁移和骨质发生分化的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objective Liraglutide ( LIRA ) is a novel antidiabetic therapy that may have anti‐inflammatory and bone protective effects. Thus, we studied the potential therapeutic effect of LIRA on periodontitis by assessing the effects of LIRA on the proliferation, migration, inflammation, and osteogenic differentiation of human periodontal ligament cells ( hPDLC s) after LPS stimulation. Material and Methods The expression of glucagon like‐peptide 1 receptor ( GLP ‐1R) was measured using qRT ‐ PCR . HPDLC s proliferation after LIRA were analyzed using MTT assays. Cell migration was quantified using a wound‐healing assay. The expression of inflammatory ( IL ‐6 and TNF ‐α) was measured by qRT ‐ PCR and ELISA in hPDLC s. The effect of LIRA on the mineralization potential of hPDLC s was assessed by alizarin red S staining. Furthermore, the expression of Runx2 and ALP was measured by qRT ‐ PCR and Western blot in hPDLC s. Results GLP ‐1R mRNA was present on hPDLC s, and LIRA increased the expression of GLP ‐1R mRNA . When cultured with 25, 50, 75, 100 and 125 nM LIRA for 24 h, hPDLC s proliferation was enhanced in a dose‐dependent manner ( P?? 0.05), and 100 nM was optimal. LIRA promoted hPDLC s migration in a time‐dependent manner. LPS significantly increased the expression of IL ‐6 and TNF ‐α ( P?? 0.01), decreased the formation of mineralization nodes ( P?? 0.01), and inhibited the expression of ALP and Runx2 ( P?? 0.05). LIRA treatment blocked the expression of IL ‐6 and TNF ‐α ( P?? 0.01), increased the formation of mineralization nodes ( P? ? 0.01), and enhanced the expression of ALP and Runx2 ( P?? 0.05). Conclusion LIRA can enhance the proliferation, migration, and osteogenic differentiation of hPDLC s and inhibit the inflammatory response. Thus, LIRA may have potential therapeutic use as an adjuvant treatment for human periodontitis, and this effect is independent of hypoglycemic activity.
机译:摘要客观Liraglutide(Lira)是一种新型抗炎症治疗,可具有抗炎和骨骼保护作用。因此,我们通过评估LIRA对LPS刺激后人牙周韧带细胞(HPDLC S)的增殖,迁移,炎症和骨质发生分化的影响,研究了LIRA对牙周炎的潜在治疗效果。材料和方法使用QRT - PCR测量胰高血糖素样肽1受体(GLP -1R)的表达。使用MTT测定分析LIRA后的HPDLC S增殖。使用伤口愈合测定量化细胞迁移。通过QRT - PCR和HPDLC S中的QRT-PCR和ELISA测量炎症(IL -6和TNF-α)的表达。利亚氧化术红S染色评估了Lira对HPDLC S矿化潜力的影响。此外,通过QRT - PCR和Western印迹在HPDLC S中测量RUNX2和ALP的表达。结果在HPDLC S上存在GLP -1R mRNA,LIRA增加了GLP -1R mRNA的表达。当用25,50,75,100和125nm Lira培养时,以24小时,以剂量依赖性方式增强HPDLC S增强(P?<0.05),并且100nm是最佳的。 Lira以时间依赖的方式促进了HPDLC迁移。 LPS显着增加了IL -6和TNF-α的表达(P?<0.01),降低了矿化节点的形成(P?<0.01),并抑制AlP和Runx2的表达(P =α& ?0.05)。 Lira治疗阻断了IL -6和TNF-α的表达(P?<0.01),增加了矿化节点的形成(p≤≤0.01),并增强了ALP和RONX2的表达(P =α& ?0.05)。结论Lira可以增强HPDLC S的增殖,迁移和成骨分化,抑制炎症反应。因此,Lira可能具有潜在的治疗用作人类牙周炎的佐剂治疗,并且这种效果与降血糖活动无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号